Trial Outcomes & Findings for Clinical Performance of a Silicone Hydrogel Lens With Use of FID 114675A (NCT NCT01240135)

NCT ID: NCT01240135

Last Updated: 2012-07-12

Results Overview

As assessed by the investigator using a composite score based on three lens fit measures: static, push-up, and centration. Static and pushup were assessed on a 5-point scale, where -2=reduced movement unacceptable, -1=reduced movement acceptable, 0=optimal movement, 1=excessive movement acceptable, 2=excessive movement unacceptable. Centration was assessed on a 3-point scale, where 0=optimal lens centration, 1=acceptable decentration, 2=unacceptable decentration. A subject with an assessment of optimal or acceptable for each measure was considered acceptable on all measurements.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

89 participants

Primary outcome timeframe

Day 14 of lens wear

Results posted on

2012-07-12

Participant Flow

Subjects were recruited from 5 US study centers.

Participant milestones

Participant milestones
Measure
FID 114576A / Renu Fresh
FID 114675A used for contact lens care per protocol-specified instructions for 14 days, followed by a minimum 1-day washout period, after which renu fresh used for contact lens care for an additional 14 days.
Renu Fresh / FID 114675A
Renu fresh used for contact lens care per protocol-specified instructions for 14 days, followed by a minimum 1-day washout period, after FID 114675A used for contact lens care for an additional 14 days.
Period One, 14 Days of Wear
STARTED
44
45
Period One, 14 Days of Wear
COMPLETED
44
45
Period One, 14 Days of Wear
NOT COMPLETED
0
0
Period Two, 14 Days of Wear
STARTED
44
45
Period Two, 14 Days of Wear
COMPLETED
43
43
Period Two, 14 Days of Wear
NOT COMPLETED
1
2

Reasons for withdrawal

Reasons for withdrawal
Measure
FID 114576A / Renu Fresh
FID 114675A used for contact lens care per protocol-specified instructions for 14 days, followed by a minimum 1-day washout period, after which renu fresh used for contact lens care for an additional 14 days.
Renu Fresh / FID 114675A
Renu fresh used for contact lens care per protocol-specified instructions for 14 days, followed by a minimum 1-day washout period, after FID 114675A used for contact lens care for an additional 14 days.
Period Two, 14 Days of Wear
Withdrawal by Subject
1
1
Period Two, 14 Days of Wear
Adverse Event
0
1

Baseline Characteristics

Clinical Performance of a Silicone Hydrogel Lens With Use of FID 114675A

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
FID 114576A / Renu Fresh
n=44 Participants
FID 114675A used for contact lens care per protocol-specified instructions for 14 days, followed by a minimum 1-day washout period, after which renu fresh used for contact lens care for an additional 14 days.
Renu Fresh / FID 114675A
n=45 Participants
Renu fresh used for contact lens care per protocol-specified instructions for 14 days, followed by a minimum 1-day washout period, after FID 114675A used for contact lens care for an additional 14 days.
Total
n=89 Participants
Total of all reporting groups
Age Continuous
34.3 years
STANDARD_DEVIATION 11.44 • n=5 Participants
31.4 years
STANDARD_DEVIATION 9.71 • n=7 Participants
32.8 years
STANDARD_DEVIATION 10.64 • n=5 Participants
Sex: Female, Male
Female
31 Participants
n=5 Participants
30 Participants
n=7 Participants
61 Participants
n=5 Participants
Sex: Female, Male
Male
13 Participants
n=5 Participants
15 Participants
n=7 Participants
28 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 14 of lens wear

Population: Intent to treat: All randomized subjects with at least one post-baseline assessment after dispensing, according to randomized treatment.

As assessed by the investigator using a composite score based on three lens fit measures: static, push-up, and centration. Static and pushup were assessed on a 5-point scale, where -2=reduced movement unacceptable, -1=reduced movement acceptable, 0=optimal movement, 1=excessive movement acceptable, 2=excessive movement unacceptable. Centration was assessed on a 3-point scale, where 0=optimal lens centration, 1=acceptable decentration, 2=unacceptable decentration. A subject with an assessment of optimal or acceptable for each measure was considered acceptable on all measurements.

Outcome measures

Outcome measures
Measure
FID 114576A
n=87 Participants
FID 114675A used for contact lens care per protocol-specified instructions for 14 days.
Renu Fresh
n=88 Participants
Renu fresh used for contact lens care per protocol-specified instructions for 14 days.
Lens Fit
100 percentage of acceptable fit
100 percentage of acceptable fit

SECONDARY outcome

Timeframe: Day 14 of lens wear

Population: Intent to treat: All randomized subjects with at least one post-baseline assessment after dispensing, according to randomized treatment.

The bulbar conjunctiva was assessed by the investigator at baseline and Day 14 utilizing a slit-lamp and ophthalmic dye. Staining coverage was scored separately in each of four regions (nasal, temporal, inferior, and superior) using a 5-point photographic reference scale, where 0=0.00% coverage and 4=10% or greater coverage. The scores for the four regions were summed, with a sum score range of 0-16.

Outcome measures

Outcome measures
Measure
FID 114576A
n=87 Participants
FID 114675A used for contact lens care per protocol-specified instructions for 14 days.
Renu Fresh
n=88 Participants
Renu fresh used for contact lens care per protocol-specified instructions for 14 days.
Mean Change From Baseline for Circumlimbal Conjunctival Staining Sum Score
0.6 units on a scale
Standard Deviation 2.49
1.4 units on a scale
Standard Deviation 2.63

Adverse Events

FID 114576A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Renu Fresh

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Director of Alcon Clinical

Alcon Research, Ltd.

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Alcon reserves the right of prior review of any publication or presentation of information related to the study.
  • Publication restrictions are in place

Restriction type: OTHER